Keywords: لوسمی مزمن میلوئیدی; EV; extracellular vesicles; ILVs; intraluminal vesicles; BMSCs; bone marrow stromal cells; AML; acute myeloid leukemia; CML; chronic myelogenous leukemia; CLL; chronic lymphocytic leukemia; ALL; acute lymphoblastic leukemia; EGF; epidermal growth factor;
مقالات ISI لوسمی مزمن میلوئیدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی مزمن میلوئیدی; ABC; ATP-binding cassette; AKT; V-Akt murine thymoma viral oncogene homolog; ALDH1; aldehyde dehydrogenase 1; AR; androgen receptor; Bad; Bcl-2-associated death promoter; Bak; Bcl-2 homologous antagonist killer; Bax; Bcl-2-associated X protein; Bcl-2; B-c
Keywords: لوسمی مزمن میلوئیدی; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CLL; B-cell chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; ERK; extracellular signal-regulated kinase; FN3; fibronectin type-III (domain); GBM; glioblastoma multiforme; JMML
Keywords: لوسمی مزمن میلوئیدی; ACC; acetyl-CoA carboxylase; ALDOA; aldolase A; AIs; aromatase inhibitors; AMPK; AMP-activated protein kinase; BC; breast cancer; CML; chronic myelogenous leukemia; CT; computed tomography; CPT1; carnitine palmitoyltransferase 1; CRC; colorectal cancer; 2
Keywords: لوسمی مزمن میلوئیدی; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ADAM; a disintegrin and metalloproteinase enzymes; ALDH; aldehyde dehydrogenase; ABC; ATP - binding cassette; BWS; Beckwith-Wiedemann syndrome; BMP; bone morphogenetic proteins; CSC; cancer s
Keywords: لوسمی مزمن میلوئیدی; JAK; Janus kinase; STAT; signal transducers and activators of transcription; EPOR; erythropoietin receptor; TPOR; thrombopoietin receptor; G-CSFR; granulocyte colony stimulating factor receptor; γc; common gamma chain; SCID; severe combined immunodeficie
Keywords: لوسمی مزمن میلوئیدی; ASH; American Society of Hematology; ATAP; amphipathic tail-anchoring peptide; BAD; BCL-2-associated death promoter protein; BAK; BCL-2 homologous antagonist killer; BAX; BCL-2-associated X protein; BCL-2; B-cell lymphoma 2; BCL-w (BCL2L2); BCL-2-like pro
Keywords: لوسمی مزمن میلوئیدی; AML; acute myeloid leukemia; MUFA; monounsaturated fatty acid; CML; chronic myelogenous leukemia; ALL; acute lymphoblastic leukemia; FAO; fatty acid oxidation; CPT1a; carnitine palmitate transferase 1a; SCD1; stearoyl CoA desaturase 1; FAB; French-America
Keywords: لوسمی مزمن میلوئیدی; Myeloproliferative disorders; Essential thrombocythemia; Polycythemia vera; Chronic myelogenous leukemia; Primary myelofibrosis;
Keywords: لوسمی مزمن میلوئیدی; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; BM; bone marrow; CML; chronic myelogenous leukemia; G-CSF; granulocyte colony stimulating factor; HIF-1α; hypoxia-inducible factor -1α; HSC; hematopoietic stem cell; IL; Interleukin; LT-HSC
Keywords: لوسمی مزمن میلوئیدی; Chronic myelogenous leukemia; K562; KG-1a; Imatinib; Synthesis
Keywords: لوسمی مزمن میلوئیدی; Stem cell transplant; Natural killer (NK) cells; Adoptive immunotherapy; Acute myeloid leukemia; Chronic myelogenous leukemia; Myelodysplastic syndrome;
Keywords: لوسمی مزمن میلوئیدی; Langmuir-blodgett monolayer; Zinc oxide; Chronic myelogenous leukemia; Cancer; Nucleic acid biosensor
Keywords: لوسمی مزمن میلوئیدی; cd3; cd3ζ; cDNA; complementary DNA; CML; chronic myelogenous leukemia; dpf; day post fertilization; e2f1/3; E2F family of transcription factor 1 and 3; foxp3; forkhead box P3; hpf; hour post fertilization; il-17; interleukin 17; ifn-γ; interferon gamma;
Keywords: لوسمی مزمن میلوئیدی; ALS; amyotrophic lateral sclerosis; ALT; alternative telomere lengthening mechanisms; ARIC; Atherosclerosis risk in communities; BP; blood pressure; CAD; coronary artery disease; CML; chronic myelogenous leukemia; CVD; cardiovascular disease; EC; endothel
Keywords: لوسمی مزمن میلوئیدی; ALK; anaplastic lymphoma kinase; ALL; acute lymphoblastic leukemia; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; CNS; central nervous system; CRC; colorectal cancer; DTC; differentiated thyroid carcinoma; DUSP; dual specificity ph
Keywords: لوسمی مزمن میلوئیدی; Afatinib (PubMed CID: 10184653); Crizotinib (PubMed CID: 11626560); Erlotinib (PubMed CID: 176870); Gefitinib (PubMed CID: 123631); Imatinib (PubMed CID: 5291); Nilotinib (PubMed CID: 644241); Sorafinib (PubMed CID: 216239); Sunitinib (PubMed CID: 5329102
Keywords: لوسمی مزمن میلوئیدی; myeloid progenitors; pulmonary arterial hypertension; chronic myelogenous leukemia; pulmonary vascular disease;
Keywords: لوسمی مزمن میلوئیدی; Myeloid leukemia; Acute myeloid leukemia; Chronic myelogenous leukemia; BCR-ABL positive; Mortality rate
Keywords: لوسمی مزمن میلوئیدی; Chronic myelogenous leukemia; Comorbid conditions; NCCN guidelines; Treatment choice; Tyrosine kinase inhibitor;
Keywords: لوسمی مزمن میلوئیدی; ALL; acute lymphoblastic leukemia; AML; acute myelogenous leukemia; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; HL; Hodgkin lymphoma; HR; hazard ratio; IOM; Institute of Medicine; ICU; intensive care unit; MM; multiple myeloma; N
Keywords: لوسمی مزمن میلوئیدی; Mathematical modeling; Delay differential equations; Chronic myelogenous leukemia; Strategic treatment Interruptions; Mathematical biology,
Keywords: لوسمی مزمن میلوئیدی; Allogeneic hematopoietic stem cell transplantation; Chronic myelogenous leukemia; Philadelphia chromosome; Tyrosine kinase inhibitor;
Keywords: لوسمی مزمن میلوئیدی; AKAP; A-Kinase Anchoring Protein; ALL; acute lymphoblastic leukemia; A.S.; activation segment; CDK; cyclin-dependent kinase; CML; chronic myelogenous leukemia; C-spine; catalytic spine; EGFR; epidermal growth factor receptor; FGFR; fibroblast growth facto
Keywords: لوسمی مزمن میلوئیدی; PCR; polymerase chain reaction; RT-PCR; reverse transcription-polymerase chain reaction; droplet-PCR; droplet-polymerase chain reaction; SNPs; single nucleotide polymorphisms; CML; chronic myelogenous leukemia; ALL; acute lymphocytic leukemia;
Keywords: لوسمی مزمن میلوئیدی; Chronic myelogenous leukemia; Bone marrow stromal cells; Tumour microenvironment; Exosomes; Interleukin 8;
Keywords: لوسمی مزمن میلوئیدی; Chronic myelogenous leukemia; Tyrosine kinase inhibitor; Resistance; BM microenvironment;
Keywords: لوسمی مزمن میلوئیدی; Myeloproliferative disorders; Essential thrombocythemia; Polycythemia vera; Chronic myelogenous leukemia; Primary myelofibrosis;
Keywords: لوسمی مزمن میلوئیدی; AML; acute myelogenous leukemia; BD; 1,3-butadiene; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; EU; European Union; DMDTC; dimethyldithiocarbamate; HIT; high-intensity task; mle; maximum likelihood estimate; MoA; mode of action;
Keywords: لوسمی مزمن میلوئیدی; Angiogenesis; Antiangiogenic agents; Angiogenic cytokines/peptides; EC; endothelial cells; VEGF; vascular endothelial growth factor; VEGF Receptor; VEGFR; FGF; fibroblast growth factor; EGF; epidermal growth factor; epidermal growth factor receptor; EGFR;
Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia
Keywords: لوسمی مزمن میلوئیدی; Chronic myelogenous leukemia; Extramedullary blast crisis; Lymphoblastic leukemia/lymphoma;
ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells
Keywords: لوسمی مزمن میلوئیدی; ZNF224; Transcription; Axl; Chronic myelogenous leukemia; Imatinib-resistance;
Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells
Keywords: لوسمی مزمن میلوئیدی; Chronic myelogenous leukemia; Checkpoint kinase 1; Bcr-Abl; Drug resistance;
Antiproliferative and interaction studies of a synthesized palladium(II) complex with human hemoglobin
Keywords: لوسمی مزمن میلوئیدی; Pd(II) complex; Chronic myelogenous leukemia; Human hemoglobin; Apoptosis;
Inhibition of ER stress-related IRE1α/CREB/NLRP1 pathway promotes the apoptosis of human chronic myelogenous leukemia cell
Keywords: لوسمی مزمن میلوئیدی; Chronic myelogenous leukemia; Endoplasmic reticulum stress; Apoptosis; IRE1α; NLRP1 inflammasome;
The second generation tyrosine kinase inhibitor dasatinib induced eryptosis in human erythrocytes-An in vitro study
Keywords: لوسمی مزمن میلوئیدی; ALL; acute lymphoblastic leukemia; [Ca2+]i; cytosolic free Ca2+ ion concentration; CML; chronic myelogenous leukemia; DPH; 1,6-diphenyl-1,3,5-hexatriene; H2DCFDA; 2â²,7â²-dichlorodihydrofluorescein diacetate; Hb; hemoglobin; IC50; the half maximal inhib
Mechanisms controlling the anti-neoplastic functions of FoxO proteins
Keywords: لوسمی مزمن میلوئیدی; ATM; ataxia telangiectasia mutated; cHL; classical hodgkin lymphoma; CML; chronic myelogenous leukemia; CSC; cancer stem cell; ERK; the extracellular signal-regulated kinase; ERα; the nuclear receptor estrogen receptor α; FoxO; forkhead box O; G6PC; glu
Femtosecond laser pulse assisted photoporation for drug delivery in Chronic myelogenous leukemia cells
Keywords: لوسمی مزمن میلوئیدی; Femto-second laser pulses; K562 cells; Chronic myelogenous leukemia; Cell fusion; And apoptosis; CML; Chronic myelogenous leukemia; fs-laser; Femto Second Laser; MTT; 3-(4, 5-Dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium bromide, tetrazole; LDH; lactate
Knockdown of ZNF233 suppresses hepatocellular carcinoma cell proliferation and tumorigenesis
Keywords: لوسمی مزمن میلوئیدی; ZNFs; zinc finger proteins; HCC; hepatocellular carcinoma; ZFNs; zinc finger factors; RNFs; ring finger proteins; PHF; PHD finger proteins; ESCs; embryonic stem cells; DMEM; Dulbecco's modified eagle's medium; MOI; multiplicity of infection; PI; propidium
Multiwalled carbon nanotube modified microfluidic-based biosensor chip for nucleic acid detection
Keywords: لوسمی مزمن میلوئیدی; Carbon nanotube; Microfluidic device; Electrophoretic deposition; Nucleic acid hybridization; Chronic myelogenous leukemia; Electrochemical impedance spectroscopy;
Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression
Keywords: لوسمی مزمن میلوئیدی; Multidrug resistance; Chronic myelogenous leukemia; Germacrone; Adriamycin; MDR1; P-glycoprotein;
IsomiR processing during differentiation of myelogenous leukemic cell line K562 by phorbol ester PMA
Keywords: لوسمی مزمن میلوئیدی; CML; chronic myelogenous leukemia; PMA; phorbol 12-myristate 13-acetate; NGS; next generation sequencing; TPM; trimmed per million; %; percentage; NET1; neuro-epithelial transforming gene 1; YARS; tyrosyl-tRNA synthetase; IPO7; importin 7; MTHFR; methylen
Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation
Keywords: لوسمی مزمن میلوئیدی; Breast Cancer; c-KIT; Epigenetics; DNA methylation; Immunohistochemistry; ADH; Atypical ductal hyperplasia; BCA; Bicinchoninic acid; CML; Chronic myelogenous leukemia; CK5/6; Cytokeratin 5/6; CK903; Cytokeratin 903; DCIS; Ductal Carcinoma in situ; ER; Est
High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity
Keywords: لوسمی مزمن میلوئیدی; HMGB1; high mobility group box 1; CML; chronic myelogenous leukemia; Ph+ALL; Philadelphia chromosome positive acute lymphoblastic leukemia; RIP1; receptor-interacting protein kinase 1; RIP3; receptor-interacting protein kinase 3; MLKL; mixed lineage kinas
The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
Keywords: لوسمی مزمن میلوئیدی; Cancer cells; PPARγ agonist; PPARγ antagonist; Therapeutic agents; Tumorigenicity; ACC; Acetyl-CoA carboxylase; AKR1B10; Alde-keto reductase 1B10; Alpha-ESA; Alpha-eleostreac acid; ACLY; ATP citrate lyase; BADGE; Bisphenol-A-diglycidyl-etter; CSCs; Canc
Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages
Keywords: لوسمی مزمن میلوئیدی; TAM; tumor associated macrophage; CD206; cluster of differentiation 206; BMDMs; bone marrow derived macrophages; Arg1; arginase 1; Mgl2; macrophage galactose N-acetyl-galactosamine specific lectin 2; Mrc1; mannose receptor C-type 1; CDH1; cadherin 1; CCL2
Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo
Keywords: لوسمی مزمن میلوئیدی; Arsenic trioxide; Cisplatin; Combination therapy; Bcr-Abl-positive leukemia; Apoptosis; APL; acute promyelocytic leukemia; ATO; arsenic trioxide; Ato-C; ATO/CDDP; CDDP; Cisplatin; CI; combination index; DRI; dose-reduction index; CML; Chronic myelogenous
DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells
Keywords: لوسمی مزمن میلوئیدی; CML; chronic myelogenous leukemia; DNMT; DNA methyltransferase; PCR; polymerase chain reaction; BSP; bisulfite sequencing PCR; MSP; methylation-specific PCR; SHP-1; Methylation; Gene silencing; DNMT1;
RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia
Keywords: لوسمی مزمن میلوئیدی; Acute myelogenous leukemia; Chronic myelogenous leukemia; FLT3; RNA binding proteins; Post-transcriptional regulation;
6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells
Keywords: لوسمی مزمن میلوئیدی; Kaempferol glucopyranoside; Saussurea stella; Interferon; JAK/STAT; SOCS3; CML; chronic myelogenous leukemia; ERK; extracellular signal-regulated kinase; HCC; hepatocellular carcinoma; JAK; janus kinase; IFN; interferon; ISRE; interferon-sensitive respons